Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all
Bellicum Pharmaceuticals's competitors and similar companies include Adaptimmune.
 Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. |  Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. | |
Founding Date | Founding Date 2004 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB |
Employees | Employees 1386% increase | Employees 4007% decrease |
Valuation ($) | Valuation ($) 778.3 k | Valuation ($) 188.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2022) | Revenue (est.) $178m (FY, 2024) |
Net income | Net income ($25m) (FY, 2022) | Net income ($70.8m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
View company